Roberto Visentin
Via Alessandro Fleming 4
Verona, 37135, Italy
Verona, 37135, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Doxorubicin PK/PD modeling in multiple myeloma: towards in silico trials.
Journal: Biology direct
Published: December 05, 2024
Smart Algorithms for Efficient Insulin Therapy Initiation in Individuals With Type 2 Diabetes: An in Silico Study.
Journal: Journal of diabetes science and technology
Published: April 22, 2024
Short- and Long-Term Effects on Glucose Control of Nonadherence to Insulin Therapy in People With Type 2 Diabetes An In Silico Study.
Journal: Journal of diabetes science and technology
Published: January 29, 2024
Tailoring the Padova Type 2 Diabetes Simulator for Treatment Guidance in Target Populations.
Journal: IEEE transactions on bio-medical engineering
Published: January 10, 2024
Modeling Doxorubicin Pharmacokinetics in Multiple Myeloma Suggests Mechanism of Drug Resistance.
Journal: IEEE transactions on bio-medical engineering
Published: October 13, 2023
Increased Insulin Secretion and Glucose Effectiveness in Obese Patients with Type 2 Diabetes following Bariatric Surgery.
Journal: Journal of diabetes research
Published: July 18, 2023
Editorial: Recent Advances in Computer Simulation for Diabetes Treatment and Care.
Journal: Frontiers in endocrinology
Published: April 07, 2022
A Novel Method for Generation of In Silico Subjects with Type 2 Diabetes.
Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Published: December 11, 2021
Modeling Pharmacokinetics of Doxorubicin in Multiple Myeloma Cells.
Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Published: December 11, 2021
A software interface for in silico testing of type 2 diabetes treatments.
Journal: Computer methods and programs in biomedicine
Published: October 12, 2021
Determinants of hepatic insulin clearance - Results from a Mendelian Randomization study.
Journal: Metabolism: clinical and experimental
Published: January 15, 2021
Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon-like peptide-1/glucagon receptor agonist SAR425899 in comparison with liraglutide.
Journal: Diabetes, obesity & metabolism
Published: January 11, 2021
Last Updated: 09/26/2026